Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 18Thoracic 10Genitourinary 10Breast 8Tumor-Agnostic 5Lymphoid 5Dermatologic 4Other hematologic neoplasm 3Gynecologic 3CNS 3Other 2Myeloid 2Sarcoma 1Plasma cell 1Head & Neck 1Classical hematology 1

Conditions

Neuroblastoma 1Neoplasms 1Meningioma 1Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Hematologic Tests × CNS × Clear all
NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated
66 enrolled
CNS

Neoplasms, Neuroblastoma

NCT05848050 2025-11-24

METALIQ

GCS Ramsay Santé pour l'Enseignement et la Recherche

Phase NA Completed
21 enrolled
CNS

Brain Neoplasms

NCT00985036 2012-04-24

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

Marquette General Health System

Withdrawn
CNS

Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡